A good move bringing someone on like Dr. Tom Duthy on to the board. His presentations are more technically focused and clearly explained than the broker podcasts. With only 4 weeks of board experience, he is also all over the story and details. The EV of the company is being compared against other drug companies at a similar phase in development. Many multiples of share price appreciation ahead and great buying opportunity at the moment in my opinion.
A good move bringing someone on like Dr. Tom Duthy on to the...
-
- There are more pages in this discussion • 39 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
